Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit has been issued an "official action indicated" (OAI) tag by the US Food and Drug Administration, which may ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility as 'official action indicated' (OAI), indicating recommended regulatory or administrative actions.
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Stock Market Today- Sun Pharmaceutical Industries share price has decline 4-5% in last two trading sessions on regulatory concerns. The US drug regulator (USFDA) post conducting an inspection at ...
Sun Pharma Advanced Research Company Ltd. (SPARC) on Wednesday announced that it is abandoning the Phase 2 study on Vodobatinib for Parkinson’s Disease. According to the company’s exchange ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Law Offices of Howard G. Smith announces an investigation on behalf of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN) inv ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
With a label expansion from the European Commission, Sobi and Apellis’ Empaveli is the first C3 inhibitor approved in the EU for the first-line treatment of paroxysmal nocturnal haemoglobinuria ...
WAUSAU, Wis. (WSAW) - April showers are still happening in the first days of May in North Central Wisconsin. The latest round of wet weather will be moving out by midnight. A bit of fog could be ...